Performance overview
Value at beginning of month: $101,388.15
Value at end of month: $101,916.25
Month over month change: +0.52%
Total CAGR: +3.34%
Related indices, monthly change
NASDAQ: +3.75%
IVV (iShares Core S&P 500): +2.27%
IBB (iShares NASDAQ Biotechnology Index): +3.02%
MXI (iShares Global Materials): +5.44%
VEGI (iShares MSCI Global Agriculture Producers): +3.48%
ICLN (iShares Clean Energy): +6.42%
Individual performances
The index continued to climb to new highs, reaching a record high during this month before dropping a few percent in the last week. Amyris turned it around, gaining over 20% this month. Horizon and Novozymes, the two most successful companies in the index, also continued to climb.
Changes made to index
None
Allocation as of July 28, 2017
